Lv1
40 积分 2025-06-26 加入
Abstract CT107: Epstein-Barr virus-specific cytotoxic T lymphocytes for treatment of rituximab-refractory Epstein-Barr virus-associated lymphoproliferative disorder
1个月前
已关闭
Safety and Antitumor Activity of Pembrolizumab in Patients With Programmed Death-Ligand 1–Positive Nasopharyngeal Carcinoma: Results of the KEYNOTE-028 Study
1个月前
已完结
Abstract CT107: Epstein-Barr virus-specific cytotoxic T lymphocytes for treatment of rituximab-refractory Epstein-Barr virus-associated lymphoproliferative disorder
1个月前
已关闭
应用EpCAM/PAN-CK荧光标记流式细胞术检测肿瘤浸润淋巴细胞中肿瘤细胞残留的研究
1个月前
已完结
Establishment of EBV-Infected Lymphoblastoid Cell Lines
2个月前
已完结
Ksd-101 in Patients with EBV-Associated Hematologic Neoplasms: Results from an Ongoing Phase I Clinical Study
4个月前
已完结
Epstein–Barr virus exploits desmocollin 2 as the principal epithelial cell entry receptor
10个月前
已完结
SATB1 is a key regulator of quiescence in stem-like CD8+ T cells
10个月前
已完结
Integrin CD103 expression in naive CD8
10个月前
已完结
Transcriptional regulator SATB1 limits CD8+ T cell population expansion and effector differentiation in chronic infection and cancer
10个月前
已完结
皖公网安备34019202002308
